ROTONDI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 3.928
EU - Europa 2.646
AS - Asia 1.786
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 3
Totale 8.373
Nazione #
US - Stati Uniti d'America 3.920
CN - Cina 1.681
IE - Irlanda 1.013
UA - Ucraina 441
FI - Finlandia 348
DE - Germania 260
IT - Italia 207
SE - Svezia 141
GB - Regno Unito 126
FR - Francia 68
JP - Giappone 62
SG - Singapore 30
BE - Belgio 18
CA - Canada 8
NL - Olanda 8
EU - Europa 5
VN - Vietnam 4
BR - Brasile 3
RU - Federazione Russa 3
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
GR - Grecia 2
IL - Israele 2
IQ - Iraq 2
LV - Lettonia 2
MU - Mauritius 2
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
KR - Corea 1
NG - Nigeria 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
Totale 8.373
Città #
Dublin 1.013
Chandler 971
Jacksonville 580
Nanjing 525
Ashburn 250
Princeton 208
Nanchang 202
Lawrence 199
Wilmington 170
Hebei 166
Shenyang 145
Changsha 140
Medford 138
Jiaxing 116
Beijing 114
Boardman 94
Helsinki 85
Ann Arbor 73
Hangzhou 65
Tianjin 65
Shanghai 63
Tokyo 62
Milan 54
New York 45
Woodbridge 45
Piscataway 35
Verona 34
Falls Church 33
San Genesio Ed Uniti 26
Norwalk 24
Seattle 20
Singapore 20
Brussels 18
Fairfield 15
Auburn Hills 14
Chicago 14
Los Angeles 13
Pavia 13
Washington 13
Falkenstein 11
Kunming 11
Tappahannock 10
Ningbo 9
Rome 9
Guangzhou 8
Taizhou 8
Zhengzhou 8
Des Moines 7
Florence 7
Jinan 7
Orange 6
Toronto 6
Bologna 5
Buffalo 5
Genoa 5
Houston 5
Redwood City 5
Dong Ket 4
Monza 4
San Francisco 4
Carbonara al Ticino 3
Dearborn 3
Quinzano d'Oglio 3
Strasbourg 3
São Paulo 3
Amsterdam 2
Arnold 2
Athens 2
Avellino 2
Bad Sobernheim 2
Baghdad 2
Cambridge 2
Changchun 2
Dhaka 2
Dorchester 2
Lanzhou 2
Las Vegas 2
Maastricht 2
Mariglianella 2
Mesero 2
Naples 2
Neviano degli Arduini 2
Ramat Gan 2
Rozzano 2
Vienna 2
Abuja 1
Altavilla Vicentina 1
Ankara 1
Augusta 1
Berlin 1
Borås 1
Brno 1
Casalgrande 1
Desio 1
Forest City 1
Fuzhou 1
Grossmuehlingen 1
Hefei 1
Ilford 1
Joliette 1
Totale 6.094
Nome #
Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. 75
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. 74
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. 73
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 70
Extraocular muscle antibodies positivity as the only serum marker of euthyroid Graves' ophthalmopathy following subacute thyroiditis: case report. 70
Graves' disease. 70
An improved polymerase chain reaction (PCR) protocol for unambigous detection of growth hormone gene deletions. 70
A Unique Patient Presenting with Concomitant Klinefelter Syndrome, Alport Syndrome and Craniopharyngioma. 68
An unusual therapeutic approach to a large thyroid nodule 67
TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer 66
THYREOTROPIN LEVELS IN DIABETIC PATIENTS ON METFORMIN TREATMENT. 65
Effect of Interferon-γ on the Basal and the TNF α-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement or the BRAF V600e Mutation 65
Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis 64
Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes. 63
Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. 62
Prevalence of Double Pituitary Adenomas in a Surgical Series: Clinical, Histological and Genetic Features. 62
A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. 61
Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. 60
Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. 60
Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. 60
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. 60
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 59
Pretransplant Positivity for Circulating Thyroid Antibodies and Graft Survival in Patients Undergoing Kidney Transplant. 59
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration 59
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard 59
CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice. 58
Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease. 58
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. 57
-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. 57
Expanding the therapeutic spectrum of metformin: From diabetes to cancer 57
Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. 56
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. 56
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? 56
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. 55
Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis. 55
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. 54
Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. 54
The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease. 54
Body weight changes in a large cohort of patients subjected to thyroidectomy for a wide spectrum of thyroid diseases 54
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. 53
Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. 53
Metodo diagnostico per la previsione di rigetto di organo trapiantato 53
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 52
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. 52
Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. 52
Toxic Diffuse Goiter (Basedow-Graves' Disease) 52
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. 51
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. 51
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study. 51
Diabetes insipidus and increased serum levels of leptin and lactate-dehydrogenase (LDH) in an adolescent boy with a primary intracranial germinoma. Case report and an endocrinological revaluation of literature. 51
Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism. 51
CB1 receptor antagonism/inverse agonism increases motor system excitability in humans. 51
Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of l-thyroxine to correct hypothyroidism 51
Prenatal measurement of testicular diameter by ultrasonography: development of fetal male gender and evaluation of testicular descent. 50
Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis. 50
Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. 50
Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association 50
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 50
Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. 49
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 49
Thyroid and obesity: not a one-way interaction 49
Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: An example of selective anti-TSH-receptor immune response 49
Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. 49
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. 48
Studying plasticity of sensory function: insight from pregnancy. 48
Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters. 48
Uso de antagonistas y/o agonistas inversos de los receptores CB1 para la preparacion de medicamentos que incrementen la excitabilidad de las motoneuronas 48
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 48
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. 47
Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. 47
Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle. 47
Interferon-B but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: A clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs 47
Etiopathogenesis of Basedow's disease. Trends and current aspects 47
Maximal stiffness evaluation by real-time ultrasound elastography, an improved tool for the differential diagnosis of thyroid nodules 47
Eight parathyroid glands incidentally discovered during a surgical intervention for secondary hyperparathyroidism: an unusual clinical finding. 46
Correlation between, clinical, biochemical, color Doppler ultrasound thyroid parameters, and CXCL-10 in autoimmune thyroid diseases. 46
The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. 46
The Amh as a predictor of ovarian reserve and the role of thyroid autoimmunity in the protocols of assisted reproduction techniques 46
Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. 46
Unusual case of cervical pregnancy after curettage for a presumptive diagnosis of intrauterine blighted ovum. 45
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 45
Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence. 45
Low serum and peritoneal fluid concentration of interferon-gamma-induced protein-10 (CXCL10) in women with endometriosis. 45
Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease. 45
Management of subclinical hypothyroidism in pregnancy: a comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association Guidelines: "The Italian Way" 45
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 45
A male patient with acromegaly and breast cancer: Treating acromegaly to control tumor progression 45
Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage 45
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion. 44
Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait 44
Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion 44
Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. 44
Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure. 43
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. 43
The influence of parity on multinodular goiter prevalence in areas with moderate iodine deficiency 42
Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism. 42
Improvement of intra-epidermal nerve fiber density in hypothyroidism after L-thyroxine therapy. 42
Estrogen receptor alpha promoter polymorphism: stronger estrogen action is coupled with lower sperm count. 42
Perfluorooctane sulfonate and perfluorooctanoic acid in surgical thyroid specimens of patients with thyroid diseases. 42
The post partum period and the onset of Graves' disease: an overestimated risk factor. 42
Totale 5.292
Categoria #
all - tutte 36.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.952 608 819 2 78 6 89 59 88 3 137 59 4
2020/2021901 90 72 21 81 2 100 95 156 33 127 100 24
2021/2022797 18 8 3 26 24 27 15 57 50 7 140 422
2022/20232.763 290 148 68 241 260 270 0 153 1.211 16 74 32
2023/20241.041 145 181 37 74 88 225 26 58 4 29 59 115
2024/202550 50 0 0 0 0 0 0 0 0 0 0 0
Totale 8.691